EV/EBITDA
36.10
+0.23+0.64%
11 min ago
Summary:
Rigel Pharmaceuticals EV/EBITDA is currently 36.10, with a rise of +0.23 (+0.64%) during the most recent trading day. Over the past year, it has increased by +47.79 (+408.81%). RIGL EV/EBITDA is now at all-time high.RIGL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +0.6% |
| 1 m1 month | +89.0% |
| 3 m3 months | +169.5% |
| 6 m6 months | +301.9% |
| ytdytd | +317.9% |
| 1 y1 year | +408.8% |
| 5 y5 years | +541.3% |
RIGL EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 36.10 | at high | 18.76 | +92.4% |
| 3 m | 3 months | 36.10 | at high | -63.59 | +156.8% |
| 6 m | 6 months | 36.10 | at high | -63.59 | +156.8% |
| 1 y | 1 year | 36.10 | at high | -63.59 | +156.8% |
| 3 y | 3 years | 36.10 | at high | -63.59 | +156.8% |
| 5 y | 5 years | 36.10 | at high | -242.79 | +114.9% |
| alltime | all time | 36.10 | at high | -242.79 | +114.9% |
Rigel Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 36.10(-317.9%) |
| 2023 | -16.57(+221.7%) |
| 2022 | -5.15(-87.5%) |
| 2021 | -41.32(+90.2%) |
| 2020 | -21.72(+283.1%) |
| 2019 | -5.67(+30.3%) |
| 2018 | -4.35(-36.5%) |
| 2017 | -6.85(+97.4%) |
| 2016 | -3.47(-24.4%) |
| 2015 | -4.59(+120.7%) |
| 2014 | -2.08(-22.4%) |
| 2013 | -2.68(-51.3%) |
| Date | Value |
|---|---|
| 2012 | -5.50(-15.1%) |
| 2011 | -6.48(-165.9%) |
| 2010 | 9.84(-325.2%) |
| 2009 | -4.37(+128.8%) |
| 2008 | -1.91(-80.2%) |
| 2007 | -9.64(+58.3%) |
| 2006 | -6.09(+114.4%) |
| 2005 | -2.84(-67.2%) |
| 2004 | -8.66(+17.0%) |
| 2003 | -7.40(+687.2%) |
| 2002 | -0.94(-90.0%) |
| 2001 | -9.41(-26.8%) |
| 2000 | -12.86 |
FAQ
- What is Rigel Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Rigel Pharmaceuticals?
- What is RIGL EV/EBITDA year-to-date change?
- What is Rigel Pharmaceuticals EV/EBITDA year-on-year change?
What is Rigel Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of RIGL is 36.10
What is the all time high EV/EBITDA for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high EV/EBITDA is 36.10
What is RIGL EV/EBITDA year-to-date change?
Rigel Pharmaceuticals EV/EBITDA has changed by +52.67 (+317.86%) since the beginning of the year
What is Rigel Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, RIGL EV/EBITDA has changed by +47.79 (+408.81%)